MSH6 and neoplasm: Given the high mutation rate of MSH6 in endometrial cancer, we not only conducted analysis in unclassified tumor samples but also innovatively verified the results in the remaining MSH6 wild-type tumor samples after removing those with MSH6 mutants and obtained consistent results with them.